Externalization of phosphatidylserine via multidrug resistance 1 (MDR1)/P-glycoprotein in oxalate-treated renal epithelial cells: implications for calcium oxalate urolithiasis

Yu-Hang Li,Shi-Liang Yu,Xiu-Guo Gan,Shang-Ha Pan,Yue-Qiu Teng,Rui-Hua An
DOI: https://doi.org/10.1007/s11255-015-1155-1
IF: 2.2662
2015-11-11
International Urology and Nephrology
Abstract:ObjectivesWe investigated the possible involvement of multidrug resistance protein 1 P-glycoprotein (MDR1 P-gp) in the oxalate-induced redistribution of phosphatidylserine in renal epithelial cell membranes.MethodsReal-time PCR and western blotting were used to examine MDR1 expression in Madin–Darby canine kidney cells at the mRNA and protein levels, respectively, whereas surface-expressed phosphatidylserine was detected by the annexin V-binding assay.ResultsOxalate treatment resulted in increased synthesis of MDR1, which resulted in phosphatidylserine (PS) externalization in the renal epithelial cell membrane. Treatment with the MDR1 inhibitor PSC833 significantly attenuated phosphatidylserine externalization. Transfection of the human MDR1 gene into renal epithelial cells significantly increased PS externalization.ConclusionsTo our knowledge, this study is the first to show that oxalate increases the synthesis of MDR1 P-gp, which plays a key role in hyperoxaluria-promoted calcium oxalate urolithiasis by facilitating phosphatidylserine redistribution in renal epithelial cells.
urology & nephrology
What problem does this paper attempt to address?